Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02729662Not ApplicableUnknown
Efficacy of Tolvaptan on ADPKD Patients
Autosomal Dominant Polycystic Kidney Disease
PrincipalinvestigatorStart date: 2016-10-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Kyorin University School of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vimal Derebail, MD, MPH

University of North Carolina, Chapel Hill

Moderately Similar
2 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Kültigin Türkmen, Fellow

Istanbul University Istanbul Medical Faculty Department of Internal Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Thomas Fehr, MD

Cantonal Hospital Graubuenden

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Marva Moxey-Mims, M.D.

NIH, NIDDK, DKUH

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Tevfik Ecder, Professor

Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Nephrology

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Hélène François, MD, PhD

Assistance Publique - Hôpitaux de Paris

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Eiji Higashihara, M.D.

Kyorin University

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease

Worked with same sponsors:

Kyorin University
Similarity Score30%

Rian Dişçi, Professor

Istanbul University Istanbul Medical Faculty Department of Public Health

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Priya Velu, MD, PhD

Weill Medical College of Cornell University

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Patrick Hofmann, MD

Cantonal Hospital Graubuenden

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02729662Not ApplicablePrincipalInvestigator

Efficacy of Tolvaptan on ADPKD Patients

Autosomal Dominant Polycystic Kidney Disease
Unknown

All 1 trials loaded